Jack C Cohen
Architects in Bethesda, MD
License number
New Jersey 21AI00492200
Issued Date
Jan 11, 1968
Expiration Date
Jul 31, 1991
Category
Architecture
Type
Registered Architect
Address
Address
Bethesda, MD
Professional information
Use Of Paramagnetic Metalloporphyrins As Contrast Agents For Tumors In Mri Imaging
US Patent:
4986256, Jan 22, 1991
Filed:
Feb 28, 1985
Appl. No.:
6/706622
Inventors:
Jack S. Cohen - Bethesda MD
Chi-Wan Chen - Silver Spring MD
Charles E. Myers - Rockville MD
Miriam Sohn - Washington DC
Chi-Wan Chen - Silver Spring MD
Charles E. Myers - Rockville MD
Miriam Sohn - Washington DC
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
A61B 1752
US Classification:
1286534
Abstract:
Water-soluble paramagnetic metalloporphyrins are used as contrast enhancing agents for magnetic resonance imaging. These agents exhibit excellent localization, non-toxicity and suprisingly high contrast enhancement in magnetic resonance imaging applications.
Inhibitors For Replication Of Retroviruses And For The Expression Of Oncogene Products
US Patent:
5276019, Jan 4, 1994
Filed:
Feb 22, 1988
Appl. No.:
7/159017
Inventors:
Jack S. Cohen - Bethesda MD
Len Neckers - Bethesda MD
Cy Stein - Gaithersburg MD
Shee L. Loke - Wheaton MD
Kazuo Shinozuka - Kazo, JP
Len Neckers - Bethesda MD
Cy Stein - Gaithersburg MD
Shee L. Loke - Wheaton MD
Kazuo Shinozuka - Kazo, JP
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
A61K 3170, C07H 1700
US Classification:
514 44
Abstract:
Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
Inhibitors For Replication Of Retroviruses And For The Expression Of Oncogene Products
US Patent:
5286717, Feb 15, 1994
Filed:
Nov 16, 1992
Appl. No.:
7/976777
Inventors:
Jack S. Cohen - Bethesda MD
Len Neckers - Bethesda MD
Cy Stein - Gaithersburg MD
She L. Loke - Wheaton MD
Kazuo Shinozuka - Kazo, JP
Len Neckers - Bethesda MD
Cy Stein - Gaithersburg MD
She L. Loke - Wheaton MD
Kazuo Shinozuka - Kazo, JP
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
A61K 3170, C07H 1700
US Classification:
514 44
Abstract:
Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
Inhibitors For Replication Of Retroviruses And For The Expression Of Oncogene Products
US Patent:
5264423, Nov 23, 1993
Filed:
Nov 16, 1992
Appl. No.:
7/976733
Inventors:
Jack S. Cohen - Bethesda MD
Len Neckers - Bethesda MD
Cy Stein - Gaithersburg MD
She L. Loke - Wheaton MD
Kazuo Shinozuka - Kazo, JP
Len Neckers - Bethesda MD
Cy Stein - Gaithersburg MD
She L. Loke - Wheaton MD
Kazuo Shinozuka - Kazo, JP
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
A61K 3170, C07H 1700
US Classification:
514 44
Abstract:
Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.